Answers are grounded in this paper and cite their sources.
See article in J. Gastroenterol. Hepatol. 2004; 19: 1206–11. A substantial number of patients with ‘idiopathic’ pancreatitis and unexplained biliary pain turn out to have small gallstones that have gone undetected by abdominal ultrasound (US) or computed tomography (CT). The term ‘biliary microlithiasis’ was coined to describe gallstones of <3 mm in diameter. In some patients with microlithiasis, biliary sludge and/or gallstones can be detected by endoscopic ultrasound (EUS), with its high spatial resolution. Microscopic examination of the bile under polarized light can detect cholesterol crystals, which are a surrogate marker for biliary sludge and gallstones. Ideally, the bile studied would be aspirated from the gallbladder by direct needle puncture or using a catheter inserted through the cystic duct during endoscopic retrograde cholangiopancreatography (ERCP). However, these approaches present significant technical difficulties and are not risk-free. In the real world bile is usually sampled from the bile duct or the lumen of the duodenum, often after stimulating the gallbladder to contract. The reported prevalence of biliary cholesterol crystals in patients with biliary pain and recurrent pancreatitis varies widely depending on patient selection, the sampling method and the technique used for analysis. Although early reports suggested that cholesterol crystals are common (33–100%) in the bile of patients with unexplained biliary pain, a recent study found them in only 3.5% of cases.1 In patients with idiopathic pancreatitis, biliary crystals suggesting microlithiasis have been found in 7–79% of cases.2–5 Data showing that small gallstones carry a higher risk for causing pancreatitis than large ones support the possible role of biliary microlithiasis in causing this disorder.6–9 However, cynics suggest that the appearance of crystals in bile may be a secondary event resulting from stasis in the setting of duodenal ileus and pancreatic head swelling.2 In a recent issue of the Journal, Saraswat et al. report the results of bile microscopy in 24 patients with idiopathic recurrent pancreatitis and 12 with unexplained biliary pain.10 All patients underwent initial evaluation with US and ERCP, which were normal. Twenty-two patients with symptomatic gallstones and 12 without gallstones or pancreaticobiliary disease served as controls. Bile was collected from the duodenum after gallbladder stimulation with ceruletide, a synthetic dectapeptide with cholecystokinin-like activity, in all but two patients in the gallstone-free control group. These two patients had bile collected by direct puncture of the gallbladder during laparotomy for unrelated diseases (gastric ulcer, mesenteric cyst). Biliary crystals were found in 75%, 83% and 95% of patients, respectively, with idiopathic pancreatitis, unexplained biliary-type pain and known symptomatic gallstones. Of the patients with recurrent idiopathic pancreatitis and biliary pain, those who proved positive for biliary cholesterol crystals underwent cholecystectomy (n = 2), endoscopic biliary sphincterotomy (EBS; n = 21) or attempted chemical dissolution with oral ursodeoxycholic acid (UDCA; n = 5). All of the patients remained asymptomatic during follow up, a period of 30 months (range: 8–48 months) for those with idiopathic pancreatitis, 18 months (range: 6–22 months) for those with biliary pain treated by EBS and 10 months for the single patient treated with UDCA. The high frequency with which cholesterol crystals were found in the bile of patients with idiopathic pancreatitis and presumed biliary pain in the study by Saraswat et al. is remarkable.10 Should we interpret this finding as evidence that microlithiasis plays a far more important role than previously appreciated in these conditions, or does it reflect some methodologic flaw in the study? Because abdominal US is used to screen patients for the presence of gallstones, it has a significant impact on patient selection. The adequacy (or inadequacy) of the US examination determines how many patients with gallstones go undetected. The identification of gallstones by US depends on multiple factors, including operator experience, interest and perseverance, the sophistication of the equipment, the patient's body habitus, whether or not the patient is truly fasting etc. Saraswat et al. do not appear to have looked for these potentially confounding variables.10 The primacy of microlithiasis in their study does not leave much room for other causes of biliary pain and recurrent pancreatitis. What about sphincter of Oddi dysfunction (SOD)? The reported prevalence of SOD in patients with idiopathic recurrent pancreatitis is not insignificant.11–13 Sphincter of Oddi dysfunction is an accepted cause of post-cholecystectomy pain: loss of the gallbladder as a pressure reservoir and/or denervation of the biliary sphincter have been proposed as etiologic factors. Sphincter of Oddi dysfunction is increasingly being identified in patients with intact gallbladders, although this phenomenon has been less rigorously studied than post-cholecystectomy SOD.14,15 The existing (Milwaukee) classification of SOD dates from 1989 and is based on a data set derived from post-cholecystectomy patients alone.16 The diagnosis of type I SOD requires attacks of ‘typical biliary pain’, elevated serum transaminases to at least 1.5-fold the upper limit of normal on two occasions (with return to normal between attacks) and dilatation of the extrahepatic bile duct to a diameter of ≥12 mm. Type II SOD requires biliary pain plus one of the other two criteria, but not both. Type III SOD is a pain syndrome only. In the USA, only major referral centers, whose large volume of procedures justifies the purchase of expensive equipment, offer biliary (and pancreatic) manometry. Sphincter of Oddi manometry (SOM) is not available in much of Europe, where SOD is often referred to disparagingly as ‘an American disease’. In the study by Saraswat et al. patients with unexplained biliary pain could have been classified as having suspected type II and type III SOD.10 Abnormal manometry confirming these diagnoses would have been expected in 25% (type III) to perhaps as many as 60% (type II) of their patients.11,17 It has been suggested that gallstones may, in fact, cause SOD: biliary and pancreatic sphincter function might be altered by mechanical irritation and subsequent inflammation resulting from stone passage.18,19 This hypothesis implies overlap between SOD and gallstones. However, the association between biliary microlithiasis and SOD has been questioned by Rashdan et al., who found no difference in the prevalence of biliary crystals between those with SOD and those without.1 At least some of the patients in the present study who had abnormal bile microscopy might have been diagnosed as having SOD had manometry been employed. Biliary-type pain is not specific for biliary tract disease. Patients with more generalized motility disorders (which may be labeled as irritable bowel syndrome [IBS] or visceral hyperalgesia) often present with similar symptoms. Such patients constitute the majority of those seen at referral centers for suspected type III SOD. Predictably, these patients respond no better to EBS than to placebo. The frequency of occult gallstones in patients with unexplained biliary pain reported by Saraswat et al. is unexpectedly high.10 The authors do not share their definition of biliary pain with us, and it is unclear how they screened out patients with non-biliary causes of their symptoms. In this study, all but seven of the patients diagnosed with biliary microlithiasis underwent EBS. The disadvantages of EBS are early and late complications of the procedure itself, as well as increased risk of cholecystitis and recurrent choledocholithiasis.20 Endoscopic biliary sphincterotomy has been advocated as an alternative to cholecystectomy to prevent biliary colic and attacks of pancreatitis in patients deemed unfit for surgery.21 However, for most patients the standard of care remains cholecystectomy.2,22 The incidence of complications of laparoscopic cholecystectomy (LC) is much lower than that of EBS. This perhaps surprising statistic results in part from the large demoninator for LC (>500 000 cases annually in the USA). Cholecystectomy should cure patients with symptoms of microlithiasis, because biliary crystals usually form in the gallbladder and are rarely observed after the organ has been removed.23 Because patients in the present study did not undergo SOM, it remains unknown what condition was treated by EBS: microlithiasis or SOD. However, even in patients with confirmed biliary sphincter hypertension, a treatment response of 100% is unheard of (especially in those with type III SOD). The study by Saraswat et al. adds to the controversy regarding biliary microlithiasis and raises important questions.10 Their data suggest a dominant role for microlithiasis in patients with idiopathic recurrent pancreatitis and biliary-type pain. This has major implications for diagnosis and treatment. Further studies are needed to determine if these results are applicable to different populations. Biliary-type pain remains poorly defined. Our understanding of the interaction between gallstones and the sphincter of Oddi, especially in the setting of an intact gallbladder, remains rudimentary. Like Tolkien's Golum, SOD is unloved and often reviled, but cannot be ignored if biliary pain and idiopathic pancreatitis are to be put in their proper context. Can cholecystectomy be justified as a diagnostic test when standard investigation fails to reveal the cause of these complaints? Statistically, gallstones remain by far the likeliest cause of idiopathic pancreatitis and biliary colic in patients with an intact gallbladder, regardless of the findings of cross-sectional imaging. Laparoscopic cholecystectomy is a much less morbid intervention than ERCP with SOM when the differential diagnosis is between suspected biliary microlithiasis and SOD type III. Empiric EBS in this setting may be an example of the endoscopic ‘biliary vandalism’ decried by some surgeons.24 Certainly, serious thought should be given to the sanctity of the sphincter of Oddi before it is ablated in the name of biliary microlithiasis. The study by Saraswat et al. does not convince us that the time has come to cut more biliary sphincters and remove fewer gallbladders.10
No takes yet. Share an insight, caveat, or question.
Gerke et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: